Serum PAI-1 is a novel predictor for response to pegylated interferon-α-2b plus ribavirin therapy in chronic hepatitis C virus infection
2011 ◽
Vol 19
(2)
◽
pp. e126-e133
◽
2008 ◽
Vol 27
(9)
◽
pp. 790-797
◽
2014 ◽
Vol 109
◽
pp. S178
2014 ◽
Vol 20
(14)
◽
pp. 4071
◽
2005 ◽
Vol 53
(1)
◽
pp. 26-30
◽
2016 ◽
Vol 6
◽
pp. S13
2011 ◽
Vol 147
(10)
◽
pp. 1232
◽